WHO Meets With Industry Leaders To Accelerate Ebola Vaccine Development

News outlets report on a meeting among WHO and pharmaceutical company representatives to discuss the research and development of Ebola vaccines.

Agence France-Presse: WHO eyes mass Ebola vaccines by mid-2015 (Fowler, 10/24).
Associated Press: WHO: Millions of Ebola vaccine doses ready in 2015 (Cheng, 10/24).
BBC News: Millions of Ebola vaccine doses by end of 2015, WHO says (Gallagher, 10/24).
The Guardian: WHO: several hundred thousand Ebola vaccine doses expected by mid-2015 (Boseley, 10/24).
New York Times: Health Officials Expect to Start Vaccine Trials in West Africa as Early as December (Pollack, 10/24).
Reuters: WHO says Ebola vaccine plans accelerating as trials advance (Nebehay/Kelland, 10/24).
Science: Ebola vaccines racing forward faster than predicted, but high hurdles remain (Cohen/Kupferschmidt, 10/24).
U.N. News Centre: Ebola: industry leaders meet to discuss vaccine trials, as U.N. agencies continue aid push (10/24).
Wall Street Journal: WHO Says Ebola Vaccine Trials Due December in West Africa (Letzing, 10/24).
World Health Organization: Summary report of a WHO High-level meeting on Ebola vaccines access and financing (10/23).
World Health Organization: WHO convenes industry leaders and key partners to discuss trials and production of Ebola vaccine (10/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.